Lifibrol - CISMeF

Preferred Label : Lifibrol;

NCIt definition : A novel lipid-lowering agent with a complicated mechanism of action. Lifibrol may affect bile acid metabolism, enhance sterol excretion, reduce cholesterol absorption, or enhance synthesis or sensitivity of the LDL receptors. In studies, its lipid-lowering effects were of a magnitude similar to that of the statins, but unlike statins, it had the ability to lower Lp(a), a risk factor in atherosclerosis.;

UNII : 6KWX9X0Q5K;

InChIKey : LNXBEIZREVRNTF-UHFFFAOYSA-N;

CAS number : 96609-16-4;

Molecule name : K12.148;

Chemical formula : C21H26O4;

Details

Origin ID

C82244;

UMLS CUI

C0125829;

Currated CISMeF NLP mapping
- lifibrol [MeSH concept]
- lifibrol [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- lifibrol [MeSH concept]
- lifibrol [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients